Preventing a Decline in Physical Function in Older Androgen-Deprived Men with Structured Exercise Training
Preventing a Decline in Physical Function in Older Androgen-Deprived Men with Structured Exercise Training
批准号:
10090555
负责人:
Shehzad Basaria
金额:
$23.03万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-02-01 至 2023-11-30
关键词:
Activities of Daily LivingAdverse effectsAgeAggressive courseAgonistAmericanAndrogen SuppressionAndrogensAttentionAttenuatedBody CompositionBody WeightCastrationClinicalControl GroupsCross-Sectional StudiesDual-Energy X-Ray AbsorptiometryEnrollmentEnsureEquilibriumEtiologyExerciseExercise TherapyExhibitsFatigueFatty acid glycerol estersFunctional disorderGoalsGonadotropin Hormone Releasing HormoneHealthHormonesInterventionIntervention TrialLaboratoriesLeadLower ExtremityMaintenanceMalignant NeoplasmsMalignant neoplasm of prostateMeasuresMedical CastrationMetastatic Prostate CancerMethodsMuscleMuscular AtrophyOrchiectomyOrganOutcomePatientsPerformancePhenotypePhysical FunctionPhysical PerformancePreventionProstateProstate Cancer therapyProstatectomyPublic HealthQuality of lifeQuestionnairesRandomizedRandomized Controlled TrialsRegimenReportingRoleSF-36ScanningSerumStandardizationStructureTestosteroneThinnessTimeTissuesTrainingUnited StatesUpper ExtremityVisitandrogen deprivation therapyandrogen sensitiveattentional controlcomparative efficacydesignefficacy evaluationexercise interventionexercise physiologistexercise regimenexercise trainingexperiencefall riskfallsflexibilityfrailtyhealth related quality of lifehigh riskimprovedinstrumentlean body massmenmuscle formmuscle strengtholder menpatient populationpreservationpreventprimary outcomeprospectiverandomized trialrecruitreduced muscle strengthresilienceresistance exercisetherapy design
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The overall goal of this proposal is to determine the efficacy of resistance exercise training in preventing the
decline in physical function in men with prostate cancer (PCa) undergoing androgen deprivation therapy (ADT).
As testosterone has a central role in the stimulation of prostate tissue, ADT is the cornerstone of treatment in
men with high grade and metastatic PCa. ADT results in castrate levels of serum testosterone and this
profound androgen deficiency leads to a reduction in lean mass and an increase in fat mass. These
perturbations in body composition follow an aggressive course in these men as loss of lean mass is evident
within 6-8 weeks of starting ADT. These unfavorable changes in body composition result in decreased muscle
strength, which in turn, results in a decline in physical function. These adverse effects have serious
consequences as men on ADT have a higher risk of frailty and falls compared with men with PCa who do not
undergo ADT and are only treated with prostatectomy. Despite declines in these functional tasks that are
patient-important and critical to maintenance of independence, not a single randomized trial has been
performed in these men to evaluate the efficacy of a structured exercise regimen in preventing decline in
physical function. A handful of previous studies had only enrolled men who were already receiving ADT and
had already encountered significant muscle atrophy; therefore, as expected, no meaningful improvements in
physical function were seen. Furthermore, previous studies did not provide equal attention to control groups.
We propose a randomized, controlled, parallel group trial to determine the efficacy of 6-months of structured
resistance exercise training in preventing the decline in physical function (assessed by loaded stair
climbing power) in men age 60 years and older who are about to begin ADT for PCa. We will also provide
equal attention to the control group using structured, patient-important, but outcome innocuous interventions
(flexibility and balance exercises). We will also evaluate the efficacy of exercise training on muscle mass
(DEXA scan), muscle strength (1RM method), QOL (SF-36 questionnaire) and fatigue (FACIT-F
questionnaire). The findings of this trial will lay the groundwork for definitive intervention trials to prevent hard
outcomes of frailty and falls in men undergoing ADT. As frailty imposes a significant public health burden and
is associated with diminished functional capacity and resilience, the proposed trial is likely to have a substantial
clinical impact in the overall health and independence of this patient population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mentoring in Endocrine and Cardiometabolic Abnormalities in Cancer and Aging
-
批准号:10469444
-
项目类别:
-
资助金额:$19.23万
-
财政年份:2021
-
负责人:Shehzad Basaria
-
依托单位:
Exploring the Role of Testosterone as a Novel Anti-Nociceptive Agent in Women with Chronic Pain and Opioid Use
-
批准号:10413965
-
项目类别:
-
资助金额:$22.38万
-
财政年份:2021
-
负责人:Shehzad Basaria
-
依托单位:
Mentoring in Endocrine and Cardiometabolic Abnormalities in Cancer and Aging
-
批准号:10300180
-
项目类别:
-
资助金额:$18.48万
-
财政年份:2021
-
负责人:Shehzad Basaria
-
依托单位:
Exploring the Role of Testosterone as a Novel Anti-Nociceptive Agent in Women with Chronic Pain and Opioid Use
-
批准号:10189910
-
项目类别:
-
资助金额:$26.85万
-
财政年份:2021
-
负责人:Shehzad Basaria
-
依托单位:
Mentoring in Endocrine and Cardiometabolic Abnormalities in Cancer and Aging
-
批准号:10652585
-
项目类别:
-
资助金额:$18.91万
-
财政年份:2021
-
负责人:Shehzad Basaria
-
依托单位:
Androgen Replacement to Improve Patient-Important Outcomes in Men with Opioid-Induced Hypogonadism
-
批准号:10266840
-
项目类别:
-
资助金额:$71.3万
-
财政年份:2020
-
负责人:Shehzad Basaria
-
依托单位:
Androgen Replacement to Improve Patient-Important Outcomes in Men with Opioid-Induced Hypogonadism
-
批准号:10118343
-
项目类别:
-
资助金额:$75.28万
-
财政年份:2020
-
负责人:Shehzad Basaria
-
依托单位:
Androgen Replacement to Improve Patient-Important Outcomes in Men with Opioid-Induced Hypogonadism
-
批准号:10426373
-
项目类别:
-
资助金额:$80.85万
-
财政年份:2020
-
负责人:Shehzad Basaria
-
依托单位:
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer
-
批准号:10223238
-
项目类别:
-
资助金额:$64.36万
-
财政年份:2019
-
负责人:Shehzad Basaria
-
依托单位:
Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency
-
批准号:9982751
-
项目类别:
-
资助金额:$67.98万
-
财政年份:2019
-
负责人:Shehzad Basaria
-
依托单位:
Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency
-
批准号:9816135
-
项目类别:
-
资助金额:$70.85万
-
财政年份:2019
-
负责人:Shehzad Basaria
-
依托单位:
Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency
-
批准号:10212212
-
项目类别:
-
资助金额:$67.36万
-
财政年份:2019
-
负责人:Shehzad Basaria
-
依托单位:
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer
-
批准号:10617171
-
项目类别:
-
资助金额:$12.52万
-
财政年份:2019
-
负责人:Shehzad Basaria
-
依托单位:
Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiency
-
批准号:10403600
-
项目类别:
-
资助金额:$67.37万
-
财政年份:2019
-
负责人:Shehzad Basaria
-
依托单位:
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of Cancer
-
批准号:9927605
-
项目类别:
-
资助金额:$66.37万
-
财政年份:2019
-
负责人:Shehzad Basaria
-
依托单位:
Hypogonadism and Pain Perception in Androgen-Deprived Men with Prostate Cancer
-
批准号:8511920
-
项目类别:
-
资助金额:$24.39万
-
财政年份:2013
-
负责人:Shehzad Basaria
-
依托单位:
Hypogonadism and Pain Perception in Androgen-Deprived Men with Prostate Cancer
-
批准号:8639503
-
项目类别:
-
资助金额:$19.11万
-
财政年份:2013
-
负责人:Shehzad Basaria
-
依托单位:
ISOFLAVONES IN PROSTATE CANCER UNDERGOING ANDROGEN DEPRIVATION THERAPY
-
批准号:7604633
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2006
-
负责人:Shehzad Basaria
-
依托单位:
ISOFLAVONES IN PROSTATE CANCER UNDERGOING ANDROGEN DEPRIVATION THERAPY
-
批准号:7378920
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2005
-
负责人:Shehzad Basaria
-
依托单位:
海外基金